Status:
COMPLETED
The Role of Modified Ultrafiltration Following Open Heart Surgery
Lead Sponsor:
Indonesia University
Conditions:
Heart; Surgery, Heart, Functional Disturbance as Result
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate the effect of combining conventional ultrafiltration and modified ultrafiltration compared to conventional ultrafiltration alone in patients who underwent open heart sur...
Detailed Description
The target of this study is adult patients diagnosed with coronary heart disease and valve disease who underwent open heart surgery in CICU PJT RSCM and Jakarta Heart Hospital. The research was conduc...
Eligibility Criteria
Inclusion
- Adult patients aged 18 years or older undergoing elective open heart surgery
- Willing to become a research participant and sign an informed consent statement
Exclusion
- Patients undergoing redo surgery and emergency surgery
- Patients that have immune disease, chronic lung disease, undergoing hemodialysis
- Patients who are pregnant
- Drop-out Criteria
- Patients who experience repeated back-on bypass
- Patients who experience reopen surgery 24 hours after surgery
- Patients who die within 24 hours after surgery
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06085066
Start Date
December 1 2021
End Date
February 29 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo Central National Hospital
Jakarta Pusat, DKI Jakarta, Indonesia